You are here

Individualized TMS Target Selection: Clinical Outcomes, Mechanisms of Action and Predictors of Response

×

Warning message

This Grand Rounds Webinar is restricted to registered participants or on-demand registrants. Click the following link to register: Register Here

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:
Individualized TMS Target Selection: Clinical Outcomes, Mechanisms of Action and Predictors of Response

Learning objectives: 

1.     Be able to understand the potential benefits of individualized Neuronavigated TMS; 

2.     Identify circuit-based predictors of TMS response;

3.     Identify the circuit-based mechanisms of action of TMS antidepressant effects. 

 

Date of Release: November 8, 2019

Date of Completion: November 7, 2021

Format: On-Demand

Cost: Members: $25 | Non-members $50 | Student Members FREE


Speakers: Joan Camprodon, MD, PhD

Dr. Camprodon is Chief of the Division of Neuropsychiatry at Massachusetts General Hospital and Assistant Professor of Psychiatry at Harvard Medical School. Clinically, he is the founding director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in Psychiatry and Behavioral Neurology & Neuropsychiatry.

Scientifically, he directs the Laboratory for Neuropsychiatry and Neuromodulation. His research uses multimodal combinations of neuroimaging and brain stimulation to investigate neural circuitry and plasticity in a translational manner. His laboratory works with a wide range of noninvasive and invasive neuromodulation techniques including transcranial current stimulation (tCS), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT) and deep brain stimulation (DBS) among others. He also uses functional and structural MRI, EEG and innovative simultaneous combinations of TMS and tDCS with neuroimaging. Dr. Camprodon is interested in understanding basic circuit properties of human neural networks and how maladaptive plastic changes lead to neuropsychiatric disorders. Critical efforts are geared towards applying the paradigms and methods of human systems neuroscience to develop high-impact clinical tools, identify targets for therapeutic action and design individualized image-guided neuromodulation treatments.

Vertical Tabs

Vertical Tabs

 

Acknowledgement of Financial and/or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

 

Physicians

 

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring material activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

 

All individuals in a position to control the content of CE are listed below.

 

First Name

Last Name

Commercial Interest:Relationship

Joan

Camprodon

NA

Bobbie

Fleming

NA

Sheryl

Morgan

NA

Randy

Pardell

Neuronetics: other

 

Questions? Email Certificate@AmedcoEmail.com